Regeneron buys bankrupt 23andMe for $256m
The sale brings attention back to privacy concerns as Regeneron now controls genetic data from millions of 23andMe customers. The post Regeneron buys bankrupt 23andMe for $256m appeared first on Medical Device Network.
The sale brings attention back to privacy concerns as Regeneron now controls genetic data from millions of 23andMe customers.
The post Regeneron buys bankrupt 23andMe for $256m appeared first on Medical Device Network.
